In addition, on comparing the OS and PFS rates in seven patients with GBM whose OS and PFS assessments were completed, we observed that the OS and PFS rates in patients with GBM tended to decrease as DKK3 expression levels increased, although this result was not statistically significant, likely due to the small sample size (Fig. 7D). This evidence concerns the gene DKK3 and glioblastoma.